Northwest Biotherapeutics has received approval from MHRA to investigate its dendritic cell-based therapy
Northwest Biotherapeutics, a biotechnology company is focused on developing personalized immunotherapies designed to treat cancers more effectively than current available treatments. Recently, Northwest Biotherapeutics, has developed DCVax personalized immune therapies for various types of tumor cancers has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for the Company’s Pediatric Investigation Plan (PIP). The development, regulatory review and regulatory approval of a PIP is a pre-requisite for the application for approval of a recently launched new medicine for adult patients suffering from cancer. The Company’s approved PIP includes 2 clinical trials for newly diagnosed pediatric high grade glioma.
About Ingenious e-Brain Solutions:-
Ingenious e-Brain Solutions provides high-quality, customized and cost-effective Technology Research, Business Research, and Intellectual Property Research solutions to industry leaders, and innovative companies across the globe. Innovation, knowledge and transparency form the basis of our company’s mission and vision. Along with cost benefits, we provide highest quality results ensuring fool-proof confidentiality and security. We are an ISO certified company with offices in India and USA.
Ingenious e-Brain Solutions has a strong team of analysts, and subject matter experts with domain proficiency which is devoted to help clients grow. Our highly qualified professionals offer tailored, value-added and cost-effective services to our clients. We believe in building long term relationships with our clients who include national and international corporations, Fortune 500 companies, world’s leading research institutes and universities as well as independent inventors.
Get in Touch:-
207-208 Welldone TechPark, Sohna Road
Sector 48, Gurugram,Haryana 122018, India
+91 124 429 4218